Valuation for Apontis Pharma AG (id:2859 APPH)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | 17.88 |
|
|
| Forward P/E | 21.96 |
|
|
| Price to sales | 2.11 |
|
|
| Price to book | 2.72 |
|
|
| Enterprise to revenue | 1.66 |
|
|
| Enterprise to ebitda | -43.05 |
|
|